Amanote Research
Register
Sign In
Variation in Rates of Oestrogen Receptor Positivity in Breast Cancer Again
BMJ
doi 10.1136/bmj.324.7332.298b
Full Text
Open PDF
Abstract
Available in
full text
Date
February 2, 2002
Authors
K. Miller
Publisher
BMJ
Related search
The Role of Oestrogen and Progesterone Receptors in Breast Cancer – Immunohistochemical Evaluation of Oestrogen and Progesterone Receptor Expression in Invasive Breast Cancer in Women
Wspolczesna Onkologia
Oncology
Radiology
Nuclear Medicine
Imaging
The Evolving Role of Oestrogen Receptor Β in Clinical Breast Cancer
Breast Cancer Research
Cancer Research
Oncology
Reproductive Risk Factors and Oestrogen/Progesterone Receptor-Negative Breast Cancer in the Breast Cancer Family Registry
British Journal of Cancer
Cancer Research
Oncology
Promoting E2f1-Mediated Apoptosis in Oestrogen Receptor-Α-Negative Breast Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
Oestrogen Receptor Status and Survival in Women With BRCA2-associated Breast Cancer
British Journal of Cancer
Cancer Research
Oncology
Hormone- And HER2-receptor Assessment in 33,046 Breast Cancer Patients: A Nationwide Comparison of Positivity Rates Between Pathology Laboratories in the Netherlands
Breast Cancer Research and Treatment
Cancer Research
Oncology
Detection of P24 Protein in Human Breast Cancer: Influence of Receptor Status and Oestrogen Exposure
British Journal of Cancer
Cancer Research
Oncology
Efavirenz Directly Modulates the Oestrogen Receptor and Induces Breast Cancer Cell Growth
HIV Medicine
Health Policy
Infectious Diseases
Pharmacology
Increased Mortality in HER2 Positive, Oestrogen Receptor Positive Invasive Breast Cancer: A Population-Based Study
British Journal of Cancer
Cancer Research
Oncology
